Last reviewed · How we verify
Trazodone Hydrochloride prolonged-release tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Trazodone Hydrochloride prolonged-release tablets (Trazodone Hydrochloride prolonged-release tablets) — Lee's Pharmaceutical Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Trazodone Hydrochloride prolonged-release tablets TARGET | Trazodone Hydrochloride prolonged-release tablets | Lee's Pharmaceutical Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Trazodone Hydrochloride prolonged-release tablets CI watch — RSS
- Trazodone Hydrochloride prolonged-release tablets CI watch — Atom
- Trazodone Hydrochloride prolonged-release tablets CI watch — JSON
- Trazodone Hydrochloride prolonged-release tablets alone — RSS
Cite this brief
Drug Landscape (2026). Trazodone Hydrochloride prolonged-release tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/trazodone-hydrochloride-prolonged-release-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab